Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,203 trials

NCT06624644
Recruiting
A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
Phase 2/3 · United States · 9 sites
Registry update: 22 Apr 2026
NCT07027072
Recruiting
Study to Evaluate the Efficacy and Safety of KDS2010 in Patients With Alzheimer's Disease With Mild Cognitive Impairment and Mild Dementia Due to Alzheimer's Disease
Phase 2 · South Korea · 8 sites
Registry update: 22 Jun 2026
NCT07199946
Recruiting
A Phase I/II Trial to Preserve Residual Insulin Secretion in Children With Recent Onset Type 1 Diabetes by Giving Verapamil
Phase 1/2 · Sweden · 2 sites
Registry update: 30 Sept 2025
NCT06907862
Recruiting
The SWITCH (Substitution of High With Low Ultra-processed Soy Protein Foods In a Guideline-based Diet inTervention for Cardiometabolic Health) Trial
Not applicable · Canada · 1 site
Registry update: 4 May 2026
NCT07649408
Recruiting
Impact of Advanced Crohn's Disease Therapies on Sleep Quality
Not applicable · Israel · 1 site
Registry update: 16 Jun 2026
NCT07011810
Recruiting
Axatilimab for Sclerotic Chronic Graft-versus-Host Disease
Phase 2 · United States · 3 sites
Registry update: 24 Sept 2026
NCT07114601
Recruiting
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Phase 1 · Canada, China, Germany, Spain, France, Japan, United States · 33 sites
Registry update: 4 Nov 2026
NCT07029581
Recruiting
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
Phase 2 · Bulgaria, Czechia, France, Italy, Serbia, United States · 63 sites
Registry update: 4 Nov 2026
NCT06687694
Recruiting
Immune Mechanisms of Antipsychotic Treatment Response
Not applicable · United Kingdom · 1 site
Registry update: 25 Mar 2026
NCT07125170
Recruiting
Immersive Virtual Reality in Cognitive Rehabilitation of Patients With Post-Stroke Cognitive Impairment
Not applicable · Chile · 1 site
Registry update: 15 Aug 2025
2024-512132-29-00
Recruiting
SAKK 08/23: Addition of Darolutamide to first line treatment of mCRPC: a randomized open label phase II trial
Phase 2 · Spain · 20 sites
Registry update: 12 Jun 2026
NCT07088068
Recruiting
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Phase 3 · Argentina, Australia, Belgium, Brazil, Canada, Switzerland, China, Czechia, Germany, Spain, France, United Kingdom, Greece, Israel, Italy, Japan, Netherlands, Poland, Romania, United States · 202 sites
Registry update: 13 Oct 2026
NCT07188012
Recruiting
Safety and Dystrophin Expression of SPOT-03 in Duchenne Muscular Dystrophy (DMD) Patients
Early phase 1 · China · 1 site
Registry update: 5 Nov 2026
NCT06712927
Recruiting
Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain Metastases
Phase 2 · United States · 1 site
Registry update: 18 May 2026
NCT07043153
Recruiting
AGR+PNI as Predictors of Systemic Lupus Erythematosus Disease Activity
Not applicable · Egypt · 1 site
Registry update: 13 May 2026
NCT06793800
Recruiting
Effect of Transcutaneous Auricular Vagus Nerve Stimulation Application on Respiratory Functions in Stroke Patients
Not applicable · 1 site
Registry update: 1 Apr 2026
NCT06176066
Recruiting
PH Sensitive MRI Based Resections of Glioblastoma
Phase 1 · United States · 1 site
Registry update: 4 May 2026
NCT07038382
Recruiting
A Study to Evaluate the Efficacy, Safety, and Tolerability of Human Sialidase Fusion Protein (HLX79) in Combination With Rituximab Injection Versus Placebo in Patients With Active Glomerulonephritis
Phase 2 · China · 17 sites
Registry update: 18 Nov 2025
2024-512753-24-00
Recruiting
A study to investigate the effect of adding venetoclax to treatment with ivosidenib and azacitidine in patients with acute myeloid leukemia (AML) with a specific gene abnormality who have not previously been treated and who are not eligible for intensive chemotherapy.
Phase 3 · Austria, Belgium, Germany, Denmark, Estonia, Spain, Finland, France, Ireland, Italy, Lithuania, Netherlands, Norway, Sweden · 97 sites
Registry update: 21 Oct 2026
NCT07039305
Recruiting
Physical Capacity Building for Chronic Stroke
Not applicable · United States · 1 site
Registry update: 8 Dec 2025

Ordered by registry start date. Freshness and sponsorship never change the order.